Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RASGRP2 Antikörper (C-Term)

Der Kaninchen Polyklonal anti-RASGRP2 Antikörper (ABIN5564284) detektiert spezifisch RASGRP2 in WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human und Maus.
Produktnummer ABIN5564284
553,77 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μL
Lieferung nach: Deutschland
Lieferung in 2 bis 5 Werktagen

Kurzübersicht für RASGRP2 Antikörper (C-Term) (ABIN5564284)

Target

Alle RASGRP2 Antikörper anzeigen
RASGRP2 (RAS Guanyl Releasing Protein 2 (Calcium and DAG-Regulated) (RASGRP2))

Reaktivität

  • 31
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
Human, Maus

Wirt

  • 28
  • 3
Kaninchen

Klonalität

  • 29
  • 2
Polyklonal

Konjugat

  • 21
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser RASGRP2 Antikörper ist unkonjugiert

Applikation

  • 21
  • 10
  • 8
  • 6
  • 4
  • 3
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 12
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    C-Term

    Verwendungszweck

    anti-RasGRP2, pAb (IG-09)

    Spezifität

    Recognizes human and mouse RasGRP2.

    Produktmerkmale

    Polyclonal Antibody. Recognizes human and mouse RasGRP2. Source: Rabbit. Applications: WB. Liquid. In PBS containing 2 mg/mL BSA and 0.05 % sodium azide. RasGRP2 functions as a calcium- and DAG-regulated nucleotide exchange factor specifically activating small GTPases, including Rap1/RAS3, through the exchange of bound GDP for GTP. It may also activate other GTPases such as RRAS, RRAS2, NRAS, KRAS but not HRAS. The protein is expressed in platelets, neutrophils and T lymphocytes. RasGRP2 functions in aggregation of platelets and adhesion of T lymphocytes and neutrophils probably through inside-out integrin activation. S587 was identified as the major PKA phosphorylation. Phosphorylation of S587 correlated with the inhibitory effect of PKA on Rap1b activation in platelets. In vitro, ERK1/2 phosphorylates RasGRP2 at Ser394 to limit its exchange activity and inhibits its ability to activate the small GTPase Rap1 that ultimately leads to decreased activation of ERK1/2 in cells.

    Aufreinigung

    Antigen affinity purified.

    Reinheit

    Antigen affinity purified.

    Immunogen

    Synthetic peptide corresponding to a human RasGRP2 sequence located at the C-terminus of the RasGEF domain.
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    In PBS containing 2 mg/mL BSA and 0.05 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Do not freeze.Keep sterile.

    Lagerung

    4 °C

    Informationen zur Lagerung

    +4°C

    +4°C

    Stable for at least 6 months after receipt when stored at +4°C.

    Haltbarkeit

    6 months
  • Target

    RASGRP2 (RAS Guanyl Releasing Protein 2 (Calcium and DAG-Regulated) (RASGRP2))

    Andere Bezeichnung

    RasGRP2

    Hintergrund

    Alternate Names/Synonyms: CalDAG-GEFI, Ras Guanyl Nucleotide-releasing Protein 2, Ras Guanyl Releasing Protein 2, CDC25-like Protein, CDC25L, Calcium and DAG-regulated Guanine Nucleotide Exchange Factor I, MCG7

    Product Description: RasGRP2 functions as a calcium- and DAG-regulated nucleotide exchange factor specifically activating small GTPases, including Rap1/RAS3, through the exchange of bound GDP for GTP. It may also activate other GTPases such as RRAS, RRAS2, NRAS, KRAS but not HRAS. The protein is expressed in platelets, neutrophils and T lymphocytes. RasGRP2 functions in aggregation of platelets and adhesion of T lymphocytes and neutrophils probably through inside-out integrin activation. S587 was identified as the major PKA phosphorylation. Phosphorylation of S587 correlated with the inhibitory effect of PKA on Rap1b activation in platelets. In vitro, ERK1/2 phosphorylates RasGRP2 at Ser394 to limit its exchange activity and inhibits its ability to activate the small GTPase Rap1 that ultimately leads to decreased activation of ERK1/2 in cells.

    UniProt

    Q7LDG7

    Pathways

    T-Zell Rezeptor Signalweg
Sie sind hier:
Chat with us!